# Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study

> **NCT07163910** · PHASE2 · RECRUITING · sponsor: **baotai Liang** · enrollment: 93 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** homoharringtonine
- **PROCEDURE:** Radical prostatectomy

## Key facts

- **NCT ID:** NCT07163910
- **Lead sponsor:** baotai Liang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-20
- **Primary completion:** 2027-09-20
- **Final completion:** 2027-12-20
- **Target enrollment:** 93 (ESTIMATED)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07163910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07163910, "Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07163910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*